BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 9583422)

  • 1. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.
    Nichols HB; Trentham-Dietz A; Hampton JM; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1212-8. PubMed ID: 15894674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study.
    Lin J; Zhang SM; Cook NR; Manson JE; Buring JE; Lee IM
    Am J Epidemiol; 2007 Apr; 165(7):794-801. PubMed ID: 17215381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and colorectal cancer risk.
    La Vecchia C; Negri E; Decarli A; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1007-10. PubMed ID: 9419395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee consumption and the risk of breast cancer.
    Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
    Contraception; 1997 Nov; 56(5):275-84. PubMed ID: 9437555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and colorectal cancer risk: a meta-analysis.
    Fernandez E; La Vecchia C; Balducci A; Chatenoud L; Franceschi S; Negri E
    Br J Cancer; 2001 Mar; 84(5):722-7. PubMed ID: 11237397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
    Schildkraut JM; Hulka BS; Wilkinson WE
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):395-402. PubMed ID: 2381616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids and colorectal cancer in Italy.
    Rossi M; Negri E; Talamini R; Bosetti C; Parpinel M; Gnagnarella P; Franceschi S; Dal Maso L; Montella M; Giacosa A; La Vecchia C
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1555-8. PubMed ID: 16896049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and hormone replacement therapy may protect against colorectal cancer.
    Contracept Rep; 1996 Nov; 7(4):10. PubMed ID: 12291811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study.
    Hannaford P; Elliott A
    Contraception; 2005 Feb; 71(2):95-8. PubMed ID: 15707557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific differences in the relationship between oral contraceptive use and breast cancer.
    Wingo PA; Lee NC; Ory HW; Beral V; Peterson HB; Rhodes P
    Obstet Gynecol; 1991 Aug; 78(2):161-70. PubMed ID: 2067757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.